First human test of cell therapy for critically ill COVID patients
Disease control
Completed
This early-stage study tested the safety of a new cell-based treatment called agenT-797 in 20 hospitalized COVID-19 patients with severe lung failure who needed a ventilator. The goal was to see if infusing these special immune cells could help control the disease and improve out…
Phase: PHASE1 • Sponsor: MiNK Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC